2024

1. Association of viral loads of influenza A (H3N2) with age and care setting on presentation—a prospective study during the 2022-2023 influenza season in Spain

   International Journal of Infectious Diseases, Vol. 143

2. Drug-induced hyponatraemia and possible related signals: Analysis of 659 cases reported to the Spanish Pharmacovigilance System and disproportionality analysis

   Medicina Clinica

3. Early estimates of nirsevimab immunoprophylaxis effectiveness against hospital admission for respiratory syncytial virus lower respiratory tract infections in infants, Spain, October 2023 to January 2024

   Eurosurveillance, Vol. 29, Núm. 6

4. Factors associated to the presence of headache in patients with influenza infection and its consequences: a 2010–2020 surveillance-based study

   Journal of Headache and Pain, Vol. 25, Núm. 1

5. Genistein supplementation has no effects on vitamin D levels in healthy Spanish postmenopausal women

   International Journal for Vitamin and Nutrition Research, Vol. 94, Núm. 3-4, pp. 171-176

6. Human T-lymphotropic virus-1 infection among Latin American pregnant women living in Spain

   IJID Regions, Vol. 10, pp. 146-149

7. Impact on the time elapsed since SARS-CoV-2 infection, vaccination history, and number of doses, on protection against reinfection

   Scientific Reports, Vol. 14, Núm. 1

8. Importancia de los Centros Nacionales de Gripe en la vigilancia de virus aviares de alta patogenicidad. El momento para One-Health es ahora

   Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 37, Núm. 2, pp. 121-126

9. Improved comprehension of influenza-related headaches: Perspectives and suggestions for incidence and prevalence of headache in influenza—Response

   European Journal of Neurology

10. Incidence and prevalence of headache in influenza: A 2010–2021 surveillance-based study

    European Journal of Neurology, Vol. 31, Núm. 8

11. Incremento de infecciones respiratorias agudas graves en niños durante la última etapa de la pandemia COVID-19

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 37, Núm. 1, pp. 58-68

12. Innate IRE1α-XBP1 activation by viral single-stranded RNA and its influence on lung cytokine production during SARS-CoV-2 pneumonia

    Genes and Immunity, Vol. 25, Núm. 1, pp. 43-54

13. MiRNome Profiling of Extracellular Vesicles in Patients with Severe COVID-19 and Identification of Predictors of Mortality

    Journal of Infectious Diseases, Vol. 230, Núm. 4, pp. 901-911

14. Microbiological and epidemiological features of respiratory syncytial virus

    Revista Espanola de Quimioterapia, Vol. 37, Núm. 3, pp. 209-220

15. Potential Effects on Elderly People From Nirsevimab Use in Infants

    Open Respiratory Archives, Vol. 6, Núm. 2

16. RSV Risk Profile in Hospitalized Adults and Comparison with Influenza and COVID-19 Controls in Valladolid, Spain, 2010–2022

    Infectious Diseases and Therapy, Vol. 13, Núm. 9, pp. 1983-1999

17. Respiratory Syncytial Virus Risk Profile in Hospitalized Infants and Comparison with Influenza and COVID-19 Controls in Valladolid, Spain, 2010–2022

    Infectious Diseases and Therapy

18. Stress and sleep deprivation-related biomarkers in saliva in patients with retinitis pigmentosa

    PLoS ONE, Vol. 19, Núm. 6 June

19. The mitochondrial signature of cultured endothelial cells in sepsis: Identifying potential targets for treatment

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1870, Núm. 2

20. The role of viral diagnostic tests in respiratory tract infections: moving forward

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 37, Núm. 3, pp. 252-256